Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Two New Naphthoquinone-Naphthalene Hybrid Dimers From a Marine-Derived Streptomyces Species
Chemistry and Biodiversity
March 2026
Yin S.
Efficacy and safety of anti-Hepatitis C virus regimens containing daclatasvir: a systematic review and meta-analysis from Egypt
Egyptian Liver Journal
December 2025
Abdel-Gawad M.
Open Access
High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam
Journal of Viral Hepatitis
November 2025
Laureillard D.
Open Access
Highly sensitive and selective β-Ni(OH)2@CNTs modified electrode for detection of Anti-Hepatitis C
Microchemical Journal
August 2025
Adolf M.L.
Cost–Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong
Digestive Diseases and Sciences
April 2021
Yuen M.F.
Open Access
Cost-effectiveness analysis of Daclatasvir/Sofosbuvir for the treatment of the HCV patients failed after the first line with second generation of DAAs in Italy
Expert Review of Pharmacoeconomics and Outcomes Research
4 May 2019
Ruggeri M.
Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia
Journal of Medical Virology
March 2019
Khosravi A.
Effectiveness and tolerability of direct-acting antivirals for chronic hepatitis C patients in a Southern state of Brazil
Brazilian Journal of Infectious Diseases
May - June 2018
Ferreira V.
Open Access
Comment on 'Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: The ANRS HC32 QUATTRO study'
European Journal of Gastroenterology and Hepatology
2018
Alavian S.M.
Reply to: “Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries”
Journal of Hepatology
December 2017
Zeuzem S.
Update on recommendations for the clinical management of hepatitis C in Iran 2017
Hepatitis Monthly
November 2017
Alavian S.M.
Open Access
HIV/HCV coinfection and the risk of cardiovascular disease: A meta-analysis
Journal of Viral Hepatitis
November 2017
Osibogun O.
The cost of successful antiviral therapy in hepatitis C patients: A comparison of IFN-free versus IFN-based regimens at an individual patient level in Australia
Clinicoeconomics and Outcomes Research
3 October 2017
Lee A.
Open Access
Budget impact and cost-effectiveness analyses of direct-acting antivirals for chronic hepatitis C virus infection in Hong Kong
European Journal of Clinical Microbiology and Infectious Diseases
1 October 2017
Li X.
Association of vitamin D binding protein polymorphisms with response to therapy in Egyptian chronic hepatitis C patients
Journal of Infection in Developing Countries
October 2017
Kamel A.M.
Open Access
Efficacy and safety of ledipasvir/ sofosbuvir for the treatment of chronic hepatitis c in persons with sickle cell disease
Clinical Infectious Diseases
1 September 2017
Moon J.
All Open Access, Green
A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening
Plos One
August 2017
Weggheleire A.D.
Open Access
Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct-acting antiviral treatment
Hepatology
August 2017
Poordad F.
Open Access
Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy
Journal of Gastroenterology and Hepatology Australia
August 2017
Kozuka R.
All Open Access, Green
The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection
Hepatology
August 2017
Balistreri W.F.
Open Access
Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens
Clinical Drug Investigation
1 July 2017
Puenpatom A.
Open Access
Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis
Hepatology
July 2017
Chen G.
Open Access